What should pharmacy leaders plan for?
Planning efforts increasingly involve questions such as:
- Do current refrigeration and freezer capacities support projected growth?
- How should medications be distributed to clinics and ambulatory locations?
- What redundancy exists during equipment failure or power interruption?
- Are monitoring systems integrated with enterprise alerting and quality programs?
- How will home delivery and last-mile distribution affect pharmacy operations?
The need for infrastructure investment extends well beyond healthcare providers. Logistics companies are making significant investments in temperature-controlled networks. UPS recently announced $48 million in global temperature-controlled infrastructure investments, reflecting growing confidence that demand for temperature-sensitive therapies will continue to expand throughout the next decade. Based on estimates from Growth Market Reports, the global cold-chain market is projected to reach $39.1 billion by 2033.
What are the biggest cold chain challenges for pharmacies?
Pharmacies will need to match this growth in their own capabilities, and ASHP reports that pharmacy leaders identify the top challenges in cold chain management as storage capacity, storage space, consistency of delivered product, temperature control/monitoring, and staffing. In acute care health systems, these medications must be distributed not only throughout the hospital, but also across affiliated clinics, physician offices, and urgent care centers. A significant challenge is safely distributing medications that require ultra-low-temperature (ULT) storage to smaller off-site locations and directly to patients’ homes. The processes and equipment to manage these medications span the full spectrum of healthcare delivery.
Beyond vaccines and refrigerators: what makes a cold chain effective?
Historically, the healthcare industry has devoted significant attention to vaccine storage. Guidance from organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) continues to inform cold-chain processes and quality management systems. The CDC Vaccine Storage and Handling Toolkit states: “An effective cold chain relies on three main elements: Well-trained staff, reliable storage and temperature monitoring equipment, and accurate vaccine inventory management.”
These principles hold true for all cold-chain dependent therapies, and the potential impact on patient care and financial loss cannot be overstated. Quality, medical-grade equipment is only the beginning. Effective cold-chain programs also depend on continuous temperature monitoring, automated alerting, data analytics, and robust inventory controls.
As temperature-sensitive therapies become a larger share of pharmaceutical spending and patient care, cold-chain management will increasingly influence both clinical outcomes and operational performance. Success will require more than refrigerators and freezers. It will depend on thoughtful planning, investment in technology and infrastructure, strong quality systems, and interdisciplinary collaboration across the healthcare continuum.
Pharmacists, who have long served as stewards of medication safety and effectiveness, are uniquely positioned to lead this transformation and ensure patients receive these innovative therapies safely, effectively, and efficiently.
